...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

TD AMERITRADE says it is Calgary but will not trade it. My cousin in the states called it to my attention and says Merrill says the same thing. Very confusing but interesting.There is little doubt that is relates to our Zenith IMHO. Carman

Share
New Message
Please login to post a reply